Skip to content

K-V Pharmaceutical’s Orphan Drug Makena: A Legal Perspective

November 15, 2012

       Law360.com’s November 13, 2012, article titled, “K-V’s Makena ITC Suit Would Create Monopoly, Pharmacies Say” (Paid/Trial Subscription may be required), is an interesting legal perspective on the recent filing by K-V Pharmaceutical with the US International Trade Commission. K-V Pharmaceutical is attempting to block pharmacies from importing an ingredient that is used to create cheaper versions of orphan drug Makena.     

References 

Orphan Druganaut October 28, 2012 Blog Post titled, “Why is K-V Pharmaceutical And Orphan Drug Makena In The News Again ?“    

Copyright © 2012-2013, Orphan Druganaut Blog.  All rights reserved.

Advertisements
Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: